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Summary: GATA family transcription factors play multiple vital roles in
hematopoiesis in many cell lineages, and in particular, T cells require
GATA-3 for execution of several developmental steps. Transcriptional
activation of the Gata3 gene is observed throughout T-cell development
and differentiation in a stage-specific fashion. GATA-3 has been described
as a master regulator of T-helper 2 (Th2) cell differentiation in mature
CD4+ T cells. During T-cell development in the thymus, its roles in the
CD4 versus CD8 lineage choice and at the b-selection checkpoint are the
best characterized. In contrast, its importance prior to b-selection has
been obscured both by the developmental heterogeneity of double nega-
tive (DN) 1 thymocytes and the paucity of early T-lineage progenitors
(ETPs), a subpopulation of DN1 cells that contains the most immature
thymic progenitors that retain potent T-lineage developmental potential.
By examining multiple lines of in vivo evidence procured through the
analysis of Gata3 mutant mice, we have recently demonstrated that GATA-
3 is additionally required at the earliest stage of thymopoiesis for the
development of the ETP population. Here, we review the characterized
functions of GATA-3 at each stage of T-cell development and discuss
hypothetical molecular pathways that mediate these functions.
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T-cell development in thymus
T-cell production in the thymus is supported by continuous,
life-long migration of T-cell progenitors derived from hema-
topoietic stem cells (HSCs) in the bone marrow (1). Most if
not all current models for lineage specification from HSCs
derive from the concept that, as cells mature, they progres-
sively lose more and more differentiation potential (Fig. 1).
HSC and multi-potential progenitors (MPPs) reside in the phe-
notypically defined LSK [lineage) (Lin))Sca1+cKithi] popula-
tion (Table 1), and early developmental induction of cell
surface fms-like tyrosine kinase 3 (Flt3) expression within
this population is accompanied by a loss of self-renewal
potential (2, 3). In comparison to MPPs, lymphoid-primed
MPPs (LMPPs) have markedly reduced erythroid potential
(4–7). While most hematopoietic lineage cells (specifically
erythroid, myeloid, and B lymphoid cells and all of their
progenitors) develop in the fetal liver and ⁄ or bone marrow,
T lymphoid cells develop in the thymus, which provides
unique microenvironmental cues that are essential for T-cell
development (8).
T-lymphocyte progenitors migrate into the thymus from the
fetal liver or bone marrow through the blood stream. Chemo-
kines, cell adhesion molecules, and their receptors
CCL25 ⁄ CCR9, CCL19-CCL21 ⁄CCR7, and P-selectin ⁄ PSGL-1
regulate this migration (9–15). The identity of thymus-hom-
ing cells continues to be controversial (reviewed in 16). These
cells have been proposed to reside in several different bone
marrow compartments that are distinguishable by their expres-
sion of different cell surface markers: LSK (17–19), Lin)cKitlo
Sca1loIL7Ra+ [common lymphoid progenitor (CLP)] (20,
21), and in the B220+ CD19) population (22, 23). Regardless
of their cellular origin, very rare (and at this point, hypotheti-
cal) thymus-seeding progenitors (TSPs) upon encountering
the thymic epithelium are thought to amplify to generate early
T-lineage progenitors (ETPs), the most immature T-cell pro-
genitors in the thymus that have been characterized (24–26).
Intrathymic ETPs constitute a cKithiLin) fraction that har-
bors all of the most potent T-cell developmental potential but
comprises only a subset of about 2–4% of all double negative
1 (DN1) stage cells (27). Very shortly after thymic entry,
these progenitors lose their B-cell potential and become speci-
fied to the T-cell lineage. The most immature subset (Flt3+) of
adult ETPs retains modest B-cell developmental potential (27,
28). Thymic epithelial cells express the Notch ligand Delta-
Table 1. Hematopoietic populations and abbreviations (mouse)
Cell population Abbreviation Cell surface phenotype
Lineage negative cells Lin)
LSK Lin)Sca1+cKithi
Hematopoietic stem cell HSC CD150+CD48)CD34)Flt3)LSK
Multipotent progenitors MPP Flt3loLSK
Lymphoid-primed multipotent progenitors LMPP Flt3hiLSK
Common lymphoid progenitors CLP Lin)IL7Ra+Sca1locKitlo
Early thymic progenitors ETP CD8)CD3)TCRb)cdTCR)NK1.1)CD11c)Mac1)
Gr1)B220)CD19)Ter119)cKithiCD25)
Double negative T cells, stage 1 DN1 CD4)CD8)CD44+CD25)
Double negative T cells, stage 2 DN2 Either Lin)cKithiCD25+ or Lin)CD44+CD25+
Double negative T cells, stage 3 DN3 Either Lin)cKitlo ⁄ )CD25+ or Lin)CD44)CD25+
Double negative T cells, stage 4 DN4 Either Lin)cKitlo ⁄ )CD25) or Lin)CD44)CD25)
Double positive DP CD4+CD8+
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Fig. 1. A model for T lymphopoiesis. Popular models for lineage specification from HSCs derive from the concept that, as cells mature, they progres-
sively lose differentiation potential. Myeloid, B and T-lineage potential are shown in orange, blue, and green, respectively. Cells that are committed to
the T lineage are shown in dark green. The identity of the thymus homing cells remains controversial. Possible homing cells are shown in dashed lines.
GATA-3 is required for the development of ETP, DN4, and CD4 SP T cells in the thymus (magenta arrow). E, erythroid lineage cells; M, myeloid line-
age cells; B, B lymphoid lineage cells.
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like 4 and activate Notch1-mediated signals, which in turn
promote T-cell development while at the same time repressing
further B and myeloid cell development (27–32). However,
the existence of T-restricted progenitors has also been
reported to emerge from multiple other physiological sites: in
fetal and adult peripheral blood (33, 34), in the fetal liver
(35, 36), in the spleen shortly after bone marrow transplanta-
tion (37, 38), and even in the normal adult mouse spleen
(39). In addition, inactivation of the transcriptional repressor
LRF in HSCs activates high levels of Notch signaling in these
cells and leads to the emergence of T-cell development in the
bone marrow as well as in other extrathymic tissues (40).
These data, taken together, suggest that prethymic T-lineage
commitment may indeed occur at reduced incidence or under
certain unusual circumstances but that T-cell development in
tissues other than the thymus is actively suppressed under
non-pathological conditions.
ETPs progress through the DN2 stage to the DN3 stage of
development. While ETPs and DN2 cells retain myeloid line-
age potential, DN3 cells have lost that potential and become
fully committed to the T lineage (41, 42). During these inter-
mediate stages of T-cell development, the Tcrg, Tcrd, and Tcrb
loci undergo rearrangement (43, 44). At the same time, pre-
T-cell antigen receptor-a (Ptcra) and Cd3e transcripts increase
(45, 46). CD3, TCRb, and pre-TCRa make up the pre-TCR
complex (reviewed in 47). Cells that have formed a functional
pre-TCR complex can develop into double positive (DP) cells,
while cells that have failed to initially produce a functional
complex rearrange the other Tcrb allele in a second attempt to
generate a functional pre-TCR complex; if rearrangements on
both alleles fail to generate an active TCRb protein, those cells
are eliminated by apoptosis. This step is referred as the b-
selection checkpoint and is essential for the development of
ab T cells. Complex transcriptional inputs, including from
RBPJ, MYB, TCF1, LEF1, E2A, HEB, GFI1, IKAROS,
RUNX ⁄CBFb, PU.1, and GATA-3 form a network under the
direct and indirect influence of Notch signaling to support T-
cell specification and commitment from multi-potential pro-
genitors (reviewed in 48). Other essential players include
cytokines and their receptors on hematopoietic cells, such as
interleukin 7 (IL7) ⁄ IL7R, stem cell factor (SCF) ⁄ cKit, Flt3
ligand, and Flt3 (27, 49–54).
The cells that survive b-selection develop into DN4 cells
and then into immature single positive (CD8+CD4)) and DP
stages of development. DP cells undergo rearrangement of the
Tcra locus, and this rearrangement results in the formation of
the mature TCRab complex. Next, the DP cells develop into
either CD4)CD8+ (CD8 SP) or CD4+CD8) (CD4 SP) cells, or
alternatively are eliminated by apoptosis. This CD8 versus
CD4 lineage choice determines mature T-cell fate and is con-
trolled by an intricate interplay between an increasingly well
understood transcription factor network, including the GATA-
3, TOX, Th-POK, and RUNX, all under the influence of TCR
signaling (55–66). Those cells bearing TCR complexes that
are able to bind to MHC survive (positive selection), while
other cells are eliminated by apoptosis (death by neglect). A
second round of negative selection at the DP and SP stages
eliminates by apoptosis the developing T cells that respond to
self-antigens.
Immature T-cell migration through the thymus ensures an
orderly progression of T-cell development by providing non-
cell-autonomous cues in discrete subregions of the thymus
(reviewed in 67). Mature CD4 SP or CD8 SP T cells exit the
thymus and home through the bloodstream to secondary lym-
phoid organs, where mature naive lymphocytes are main-
tained and where adaptive immune responses are initiated.
Cytokines, their signaling pathways, and tissue-restricted tran-
scription factors form an elaborately orchestrated network that
maintains the proper continuous production of T cells. GATA-
3 is one of the essential factors for T-cell development and dif-
ferentiation, and its importance has been demonstrated from
the beginning (in thymic ETPs) to the end of T-cell life (in
peripheral Th2 CD4+ T cells).
Transcription factor GATA-3 is vital for T-cell
development
At the time we originally cloned GATA-3, we found that it was
the sole member of the GATA zinc-finger-type transcription
factor family expressed in T lymphocyte cells (68). Six GATA
factors have been identified in mammals (68–71), and all
members appear to bind to a WGATAR recognition sequence
found in the promoters and ⁄or enhancers of literally thousands
of tissue-restricted genes (72, 73). Hematopoietic cells (as do
some additional tissues) express the ‘hematopoietic’ factors:
GATA-1, GATA-2, and GATA-3. Each tissue and cell lineage
expresses only very specific GATA factors, and only at very spe-
cific stages of maturation or development (Table 2). GATA-1 is
essential for the development of erythroid cells, for the prolif-
eration and ⁄ or maturation of megakaryocytes, for the produc-
tion of circulating blood platelets, for the differentiation of
eosinophils, and for mast cell differentiation (74–78). GATA-2
is required for proliferation ⁄ survival of early hematopoietic
progenitors as well as for mast cell formation (79–82). GATA-
3 is vital for the development of T cells in thymus (56, 57, 83–
85), Th2 differentiation of peripheral CD4+ T cells (86–99),
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maturation of bone marrow natural killer (NK) cells (100),
and development of thymic NK cells (101).
GATA-2 and GATA-3 are also expressed and play key devel-
opmental roles in a wide variety of non-hematopoietic tissues.
GATA-3 is essential for norepinephrin biosynthesis in sympa-
thetic ganglia and the adrenal gland, and consequently Gata3
null mutant fetuses die at around e11 of a secondary cardiac
insufficiency (102–104). This was definitively shown to be
the case by rescuing Gata3 null mutant embryos to birth by
feeding of pregnant intercrossed dams with catecholamine
intermediates (103, 105). GATA-3 has also been shown to
participate in development of the Wolffian duct and meta-
nephric kidney (103, 104, 106), in hair follicle development
and skin cell lineage differentiation (107, 108), in develop-
ment of the luminal epithelium of the mammary gland (109,
110), as well as in the differentiation of multiple tissues
derived from the pharyngeal arches, such as the jaw, parathy-
roid gland, and thymus (103, 111).
Expression of GATA-3 during T-cell development
During hematopoiesis, the Gata3 gene is first transcriptionally
activated in HSCs, defined variously as either IL7Ra)Thy1.1loLSK
(112) or CD38+CD34)LSK (113) or Thy1.1loLSK (114) or
CD34)Flt3)LSK (7). The VCAM1)Flt3hi sub-fraction of MPPs
expresses Gata3 mRNA (6). CLPs (112, 115) and pre-pro-B
cells (Hardy fraction A) (115), which retain both T-cell and
B-cell developmental potential, also express Gata3 mRNA in
the bone marrow. In the thymus, Gata3 mRNA is expressed in
the earliest ETPs that have been identified (27). Gata3 mRNA
levels gradually increase between the ETP and DN3 stages and
slightly diminish again in DN4 cells (46, 116). At the DP
stage, Gata3 mRNA and protein are both repressed and then
Gata3 transcription is strongly induced in late DP stage and
remains high at the CD4 SP stage, while diminishing in CD8
SP cells (56, 84, 117).
GATA-3 is required at very early stages of T-cell
development
The involvement of GATA-3 during early stages of thymopoi-
esis was first suggested in 1996 following the analysis of
hematopoietic cells that had diminished GATA-3 expression as
a result of antisense experiments (118). These investigators
introduced antisense oligonucleotides into e13 Lin)cKit+ fetal
liver cells or thymocytes and examined their development into
Thy1+ cells in fetal thymus organ culture. The introduction of
antisense oligonucleotide into fetal liver progenitors resulted
in diminished Thy1+ cell development to <20% of control
(nonsense oligonucleotide-transfected) cells. At the same
time, the introduction of antisense oligonucleotides into fetal
cKit+ thymocytes resulted in an approximately 50% reduction
in Thy1+ cell development. Although alternative explanations
were possible, the greater T-cell attenuation observed among
the transfected fetal liver progenitors suggested that GATA-3
might be important for T lymphopoiesis, even before thymic
entry.
Additional in vivo evidence for the involvement of GATA-3
in early T-cell development was provided in experiments that
generated blastocyst chimeras starting with Gata3-null
embryonic stem (ES) cells (either Gata3) ⁄ z null or control
Gata3+ ⁄ z heterozygous ES cells, both carrying a LacZ knock-in
allele) (84). The contribution of the mutant cells was detected
using infused fluorescein di b-D-galactopyranoside (FDG), a
substrate that fluoresces upon cleavage by b-galactosidase.
These investigators observed 2.2% FDG+ cells in DN1 thymo-
cytes of Gata3+ ⁄ z heterozygous ES chimera, but only 0.4% in
Gata3) ⁄ z (null mutant) ES chimeras. The data indicated that the
contribution of Gata3+ ⁄ z heterozygous ES cells to the T-cell
lineage was about 10% in blastocyst chimeras, as compared to
50–70% in the rest of the body (heart, brain, kidney, and
lungs). Furthermore, the contribution of Gata3) ⁄ z null ES cells
to the DN1 population was even lower, suggesting a dosage-
sensitive requirement for GATA-3 in DN1 thymocytes. How-
ever, since relatively abundant NK1.1+ cells are also contained
within the DN1 fraction (27, 85, 119) in which ETPs are
sparse (2–4% of DN1 cells) (27), and given the fact that
GATA-3 activity is known to be required for thymic NK cell
development (101), the data were sufficiently equivocal that
it was impossible to conclude decisively that GATA-3 was
required for the development of early T-cell progenitors.
To gain more precise insight into the earliest stage at which
GATA-3 becomes required for T-cell development prior to the
b-selection checkpoint, we examined the development of
immature T cells in multiple Gata3 mutant backgrounds: in
Gata3 hypomorphic mutant embryos, in irradiated adult mice
reconstituted with Gata3 null or hypomorphic mutant hemato-
poietic progenitor cells, and in adult mice in which the Gata3
gene was conditionally ablated (85). In reconstituted mice,
Gata3z ⁄ z (null) mutant hematopoietic cells showed normal
Table 2. Expression of GATA factors in various hematopoietic lineages
Hematopoietic progenitors GATA-1, GATA-2, GATA-3
Erythroid cells GATA-1
Megakaryocytes GATA-1, GATA-2
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contributions to the bone marrow HSC, LMPP, CLP and Fr.A
early hematopoietic compartments, all of which retain T-cell
developmental potential. In contrast, the absolute number of
Gata3z ⁄ z ETPs in HSC-repopulated recipient mice was <10% of
heterozygous controls. In those reconstituted animals, devel-
opment of DN2 and later stage T cells was even more signifi-
cantly impaired, to <1% of controls. Consistent with these
adoptive transfer experiments, conditional compound mutant
(Gata3flox ⁄ flox:TgMx1cre) mice bearing activated Cre generated
fewer than 3% of normal ETP numbers when compared to
control (Gata3flox ⁄ +:TgMx1cre) Cre-activated animals.
To examine the possible direct involvement of GATA-3 in
the development of fetal ETPs, we took advantage of Gata3
hypomorphic mutant (Gata3g ⁄ g) mice. Earlier experiments
showed that GATA-3 is expressed during embryogenesis in
the third pharyngeal pouch, from which the thymic epithe-
lium develops (our unpublished observations). While drug-
rescued Gata3 null mutant embryos develop no detectable thy-
mus (103), homozygous Gata3 hypomorphic mutants indeed
develop small thymi, and within those hypomorphic Gata3g ⁄ g
thymi, embryos generated 16% or 13% of normal ETP num-
bers when compared to wildtype at e15.5 or e18.5, respec-
tively.
Enforced expression of GATA-3 by retroviral transduction
has been shown to induce cKit expression (45, 120), and so
to ask whether the observed reduction in mutant ETP and
DN2 cells might be a simple consequence of reduced cKit cell
surface expression, we analyzed the number of Lin)DN1 cells
in Gata3 mutant animals. Indeed, careful gating on Lin) thy-
mocytes has been shown to enrich for bona fide ETPs within the
DN1 population (27). The absolute number of those Lin)DN1
cells was reduced in both the Gata3g ⁄ g hypomorphic mutant
embryos and in Cre-induced (Gata3flox ⁄ flox:TgMx1cre) Gata3 condi-
tionally mutant animals (85). The summary data consistently
demonstrated that GATA-3 is required for the development of
ETPs, while at the same time it appears to be dispensable for
the development of prethymic T-cell progenitors.
How does GATA-3 control ETP development? Since we
observed no developmental impairment in prethymic progen-
itors but a severe reduction in the earliest Gata3 null T-cell
population, we considered four possibilities: that GATA-3
controls (i) homing of prethymic progenitors into the thy-
mus; (ii) the differentiation of TSPs to ETPs; (iii) ETP prolifer-
ation, and ⁄or (iv) ETP viability. Since Gata3 mutant fetal livers
generated fewer Lin)CD27+cKithiCD25) cells (corresponding
to prethymic lymphoid progenitors plus thymic ETPs) (17,
121) in vitro in OP9-DL1 co-cultures, we tentatively concluded
that a homing deficiency was unlikely to be a primary cause
of the reduced ETP numbers observed in the Gata3 mutants
(85). However, we have not directly examined the thymus
homing potential of Gata3 mutant progenitor cells, so a role
for GATA-3 in thymus homing remains possible.
Blood-borne thymic seeding progenitors (TSPs) are thought
to be extremely rare and their exact identity is unknown. The
most immature subset of adult ETPs expresses the Flt3 cyto-
kine receptor (27). To determine whether the reduced num-
ber of ETPs in the Gata3 mutants was caused by a
differentiation arrest from early to late ETP subsets, we hoped
to analyze the development of early ETP (Flt3+ ETP) and late
ETP (Flt3) ETP) in adoptive transfer recipients. Unfortunately
the very low frequency of ETP recovery from the mutants
(<10% of the normal adult ETP population) precluded recov-
ery of consistent, reliable data. Analysis of Gata3g ⁄ g hypomor-
phic mutant cells in adoptive transfer recipients should be a
more useful approach in this regard.
To address the third possibility, we examined the cell cycle
status of Gata3 mutant cells. The percentage of e18.5 Gata3g ⁄ g
ETP in S phase was very slightly higher than in Gata3+ ⁄ + ETP
(our unpublished data). To examine the cell-cycle status in
the complete absence of GATA-3, we again employed OP9-
DL1 co-cultures. When compared to wildtype Gata3, we again
observed a slightly higher percentage of cells in S phase
among Gata3z ⁄ z Lin)CD27+cKithiCD25) cells. Thus, decreased
cycling also cannot explain the dearth of ETPs in Gata3-defi-
cient mice.
We also examined the viability of Gata3 mutant T-cell pro-
genitors. Since rapid clearance of dead cells by phagocytes in
the thymus (122) might conceal small differences in cell lon-
gevity, we analyzed the viability of mutant cells in OP9-DL1
co-cultures by Annexin V staining. We observed no increase
in the percentage of Annexin V+ cells in comparison to wild-
type progenitors. Taken together, these data deductively sug-
gest that the major GATA-3 cell-autonomous role in
thymopoiesis is to control the differentiation of TSPs to ETPs
and other downstream progenitors rather than participating in
cell survival or proliferation, although further studies will be
required to confirm or refute this hypothesis.
Since GATA-3 has been implicated in the control of differ-
entiation at early stages of T-cell development, one might
wonder if enforced expression of GATA-3 in multipotent pre-
thymic progenitors might trigger precocious or unusually
robust T-lineage development. However, the opposite was
found to be true. Retroviral overexpression of GATA-3 in
mouse bone marrow Thy1.1loLSK cells reportedly induced
megakaryocyte and erythroid differentiation (123). Forcibly
overexpressed GATA-3 by retroviral infection of mouse fetal
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liver progenitors caused impaired development of DN2, DN3,
and DP T cells in fetal thymus organ culture (45). In a third
study, retrovirally forced expression of GATA-3 in mouse fetal
liver LSK or dedicated lymphoid progenitors was reported to
block the development of DN2 and DN3 T cells in OP9-DL1
co-cultures (120). These results collectively suggest that
GATA-3 activity must be kept low in prethymic progenitors in
order to induce the initiation of T-cell fate and that the activa-
tion of Notch signaling, which is able to promote T-cell devel-
opment (29, 124), cannot overcome the repressive effects of
non-physiologically elevated levels of GATA-3.
Gata3 null mutant ES cells contribute to both B and myeloid
cells in ES chimeric mouse bone marrow (83), and Gata3 null
mutant e11.5 fetal liver cells generated similar numbers of
B220+ cells as control progenitors in OP9 co-cultures (125).
Gata3 null and Gata3 hypomorphic mutant hematopoietic pro-
genitor cells showed neither increased nor decreased develop-
ment of B or myeloid cells in the bone marrow and peripheral
blood in adoptive transfer experiments (85). Furthermore,
Gata3 hypomorphic embryos displayed normal development
of B, myeloid, and erythroid cells in progenitors recovered
from e18.5 fetal liver or spleen (85). These data demonstrate
that GATA-3 is dispensable for the development of all B-line-
age and myeloid cells.
GATA-3 is required at intermediate stages (DN2 to
DN4) of T-cell development
The contribution of GATA-3 to intermediate stages of T-cell
development has been demonstrated by conditional Gata3
ablation in DN2-DN3 thymocytes using the Lck promoter to
direct the expression of Cre recombinase (Gata3flox ⁄ flox:TgLckcre)
(57). This mutant mouse accumulated abnormally abundant
DN3 cells and a reduced number of DN4 and later stage
T cells. Gata3flox ⁄ flox:TgLckcre DN3 thymocytes rearranged the Tcrb
gene, but DN4 cells had less intracellular TCRb protein than
wildtype and an increased percentage of Annexin V+ apoptotic
cells (57). These data suggest that Gata3 deficient cells fail to
form sufficient pre-TCR complex and are eliminated by apop-
tosis. A transgenic rescue attempt with DO11.10, which
carries an major histocompatibility complex (MHC) class
II-restricted rearranged TCR, failed to rescue reduced DP and
SP T cells in the mutants (57). This failure suggested that
GATA-3 must play an unidentified role in addition to the
pre-TCR complex formation for the progression from the
DN3 to DN4 stage. In contrast to thymocytes at the adult
stage, the introduction of ROG (purported to be a natural
inhibitor of GATA-3 in Th2 cells) (126), into mouse e14.5
fetal thymocytes (composed mostly of DN1-DN3 cells that
have not yet been subject to b-selection) had little effect on
TCRb+ cell numbers in fetal thymus organ cultures (56). In
our studies, Gata3g ⁄ g hypomorphic embryos had a normal
DN4 ⁄ DN3 profile compared to controls, but Gata3g ⁄ g cells
indeed showed developmental defects at the adult DN3 to
DN4 transition in adoptive transfer recipients (85). These data
suggest that b-selection is less sensitive to reduced GATA-3
protein abundance in fetal than in adult thymi. Successful
rearrangement of Tcrd and Tcrg genes at the DN2-DN3 stage is
also necessary for the generation cdT cells in the thymus.
GATA-3 is expressed in cdT cells (85), but its requirement or
role in thymic cdT cells is not known.
Forced expression of GATA-3 in human CD34+CD3)
CD4)CD8) immature thymocytes (prior to Tcrb gene rear-
rangement) (127) caused enhanced initial development
toward the DP stage in fetal thymus organ cultures, while
inducing a severe reduction in thymic cellularity after day 10
(128). In contrast, retroviral forced expression of GATA-3 in
e14.5 to e15.5 DN1 and DN2 thymocytes inhibited differenti-
ation into DP cells in fetal thymus organ cultures and in OP9-
DL1 co-cultures (45, 120). In the absence of Notch signaling,
forced expression of GATA-3 in mouse DN1 and DN2 fetal
thymocytes promoted mast cell differentiation, a latent intrin-
sic potential of normal DN1 and DN2 thymocytes (120).
Under normal physiological conditions, both GATA-2 and
GATA-1 are expressed in mast cells and play essential roles in
their differentiation (78, 80). Since GATA family proteins can
apparently all bind to the GATA core DNA element (72, 73)
and have been shown to be at least partially compensatory
(129, 130), it is possible that more abundant GATA-3 gener-
ated in the forced expression models drives ectopic expression
of genes that are under the control of either GATA-1 or GATA-
2. We conclude that finely tuned levels of GATA-3 activity are
required to survive the b-selection step in adult thymi. In
support of this argument, we have shown previously that
transcriptional regulation can be exquisitely sensitive to the
absolute abundance of a transcription factor in vivo (131).
GATA-3 is required at late stages (DP to SP) of T-cell
development in the thymus
GATA-3 expression is re-induced between early DP and late
DP stages and remains high at the CD4 SP stage, while dimin-
ishing in CD8 SP T cells (56, 84, 117). It was found that
forced transgenic expression of GATA-3 throughout T-cell
development, achieved by placing it under the control of the
human CD2 promoter ⁄ LCR (132, 133), did not impede thy-
mocyte development but induced apoptosis and inhibited the
final maturation of CD8 SP T cells in the thymus (134). Forced
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expression of GATA-3 in e16.5 thymocytes that were
enriched for DP cells resulted in reduced generation of abun-
dant TCR cell surface expression and increased CD4 ⁄CD8
ratios in fetal thymus organ cultures (56). Mice that were con-
ditionally ablated for Gata3 at the DP stage and beyond using a
Cd4-directed Cre transgene (Gata3flox ⁄ flox:TgCd4cre) generated
reduced numbers of CD4 SP cells but normal numbers of CD8
SP cells (57). Inhibition of GATA-3 by retroviral introduction
of ROG or anti-GATA-3 shRNAs into e14.5 to e16.5 thymo-
cytes decreased the percentage of CD4 SP cells among the
transduced TCRbhi cells that emerged from fetal thymus organ
cultures (56). These results demonstrate that GATA-3 is
required for CD4 SP cell development after positive selection.
GATA-3 promotes and is required for Th2
differentiation of peripheral CD4+ T cells
Peripheral naive helper CD4+ T cells differentiate into several
subsets that produce distinct patterns of cytokines (reviewed
in 135, 136). GATA-3 is highly expressed in Th2 cells, but not
in Th1 cells (86, 87). Enforced expression of GATA-3 by either
retroviral infection or transgenic means promotes Th2 differ-
entiation and inhibits Th1 differentiation (88, 92, 94), while
inhibition of Gata3 using either small interfering RNA (siRNA)
or conditional Gata3 deletion significantly limits Th2 differen-
tiation (95, 96, 98). Furthermore, GATA-3 plays roles in the
chromatin modification of Th2 cytokine loci, including the Il4,
Il5, and Il13 genes (90, 91, 93, 97, 99). These data indicate
that GATA-3 is a master regulator of Th2 differentiation.
Target genes of GATA-3 in T cells
GATA-3 is presumed, or in a few cases known, to control T-
cell development by trans-activation of various stage-specific
target genes. What are the functional targets of GATA-3 dur-
ing development from prethymic progenitors to ETPs?
Although this is of course a critical question since this is the
first currently documented stage to require GATA-3 activity in
early hematopoiesis, no conclusive data are available so far
from GATA-3 loss- or gain-of-function experiments. The very
low number of ETPs and developmental arrest produced at or
before ETP stages in Gata3 mutants make it difficult to discrim-
inate loss of direct control by GATA-3 from loss of certain cell
populations in the absence of GATA-3. The gain-of-function
experiments (45, 120, 123) do not appear to have identified
target genes that would explain the crucial importance of
GATA-3 in these early stages.
During intermediate stages of T-cell development, one
important cluster of target genes that are regulated by GATA-3
is the Tcr genes. We and others have shown that GATA-3 binds
to enhancer and promoter elements of the Tcrb, Tcrg, and Tcrd
genes (137–139). However, adult mice that were condition-
ally ablated for Gata3 at the DN2-DN3 transition (in
Gata3flox ⁄ flox:TgLckcre mice) showed normal levels of Tcrb mRNA
but reduced intracellular TCRb protein in DN3 and DN4 cells
(57). These data suggest that GATA-3 may somehow regulate
TCRb expression post-transcriptionally. GATA-3 binds to the
Rag2 promoter in gel mobility shift assays (140), but condi-
tionally mutant Gata3 mice show normal rearrangement of the
Tcrb gene (57), indicating that GATA-3 is dispensable for Tcrb
gene rearrangement. A transgenic rescue attempt with
DO11.10, which carries an MHC class II-restricted rearranged
TCR, failed to rescue reduced DP and SP T cells in the mutants
(57). This failure suggested that GATA-3 must control a cur-
rently unidentified gene(s) that is critical for the development
from the DN3 to DN4 stage.
To identify transcriptional target genes of GATA-3 prior to
b-selection, GATA-3 was forcibly expressed by recombinant
retroviral infection of e14.5 fetal thymocytes (which are prin-
cipally composed of DN cells that have not yet undergone b-
selection), and changes in gene expression were analyzed
24 h postinfection (45, 120). Abundant ectopic expression of
GATA-3 in these progenitor T cells activated Hes1, a direct tar-
get of the Notch signaling pathway that is known to be impor-
tant for DN cell development (141) and at the same time
represses the Sfpi1 gene encoding PU.1. PU.1 gradually dimin-
ishes in abundance from the DN1 to DN3 stages and has been
shown to block T-cell development when forcibly expressed
in T-lymphocyte progenitors (142). Based on the short-term
response to Notch signaling, PU.1 and GATA-3, Georgescu
et al. (143) proposed a basic gene regulatory network during
the DN stages. It will be important to provide new inputs and
insights to this proposed framework and to experimentally
assess the relationships amongst these factors. In contrast,
forced expression of GATA-3 in T-cell progenitors exerted lit-
tle effect on many other genes that are important for T-cell
development, including Il7r, Ptcra, Rag1, Rag2, CD3e, Myb, Tcf7,
Lef1, E2a, Gfi1, Ikzf1, Runx1, and Notch1 (45, 120). Remarkably,
forced GATA-3 expression also activated mast cell genes such
as cKit, Gata1, Gata2, Mitf, Cpa3, and Tal1 (120). Although Hes1
was induced, an overall increase in Notch signaling was not
observed after forced expression of GATA-3, because Dtx1
transcripts (another downstream target of Notch signaling
pathway) (144) were reduced in this experiment (45, 120).
However, forced expression of GATA-3 by recombinant retro-
viral infection of bone marrow cells isolated from 5-FU trea-
ted mice induced Dtx1 (145). Since Dtx1 and Dtx2 compound
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knock-out mice have no defect in T-cell development (146),
any putative role for GATA-3 in Dtx1 expression needs to be
analyzed more carefully at each T-cell developmental step
(assuming that the Dtx1 mutant animals are indeed true nulls)
(147). In addition to gain-of-function experiments, loss-of-
function experiments will be essential to identify bona fide
GATA-3 targets. In this regard, the Gata3 hypomorphic mutant
mice (85) should prove to be invaluable, since ETP develop-
ment is reduced but not completely missing in these mice and
the development of the hypomorphic DN4 cells from DN3
cells is compromised in adoptive transfer animals.
During the CD4 versus CD8 lineage choice, GATA-3 directly
regulates the Zbtb7b gene, which encodes the zinc finger tran-
scription factor Th-POK (66). Transgenic forced expression of
Th-POK in DP and SP T cells under the control of the human
CD2 promoter ⁄ LCR inhibited CD8 SP cell development and
caused re-direction of MHC class I-restricted CD8 SP cells to
differentiate into CD4 SP cells. Furthermore, the loss of DNA
binding activity of Th-POK caused by point mutation of the
zinc finger coding sequence in the Zbtb7b gene redirected
MHC class II-restricted CD4 SP cells to differentiate into CD8
SP cells (60, 61). Since transgenic expression of Th-POK failed
to rescue the defect in CD4 SP cell development that is
observed in the absence of Gata3 (66), a gene(s) in addition to
Th-POK that regulates CD4 SP cell development downstream
of GATA-3 is likely to exist. Although GATA-3 binds to
upstream regulatory sequences of the Cd8a gene (148), neither
cell surface protein analysis nor reverse transcriptase polymer-
ase chain reaction revealed any change in expression of CD8
or CD4 in Gata3 mutant DP cells (56, 57).
During Th2 activation, GATA-3 induces the expression of
Th2 cytokine genes (Il4, Il5, and Il13) coincident with multi-
ple changes in chromatin modification (86, 87, 90, 91, 93,
97, 99). GATA-3 induces the Bhlhe41 gene that encodes the
basic helix-loop-helix transcription factor DEC2, which is spe-
cifically expressed in Th2 cells, is essential for Th2 differentia-
tion, and promotes the expression of Th2 cytokines (149).
GATA-3 also restricts Th1 differentiation by inhibiting Stat4
transcription (88, 150) and directly represses Ifng (99). Chro-
matin immunoprecipitation (ChIP) experiments showed that
GATA-3 binds to conserved non-coding sequences of the
Th1-specific Il18r1 gene in Th2 cells (151). Forced GATA-3
expression in naive CD4+ T cells from wildtype or Il4-defi-
cient mice represses Foxp3 mRNA, the key transcription factor
gene in regulatory T cells (152). Similar repression is
observed in human naive CD4+ CD45RA+ T cells, and ChIP
experiments revealed the binding of GATA-3 to a palindromic
GATA site of the FOXP3 gene in Th2 cells but not in induced
Treg cells (153). These data initially indicate that Foxp3 might
be directly repressed by GATA-3.
In attempting to identify direct targets of GATA-3 and TBET
in human Th1 and Th2 cells, GATA-3 was immunoprecipitat-
ed in ChIP assays followed by hybridization of the recovered
DNA to microarrays containing probes for 8 kbp surrounding
the transcription start sites of 18,450 protein-coding genes
(ChIP-Chip) (154). This experiment identified 344 GATA-3-
bound genes, including both Th2 and Th1. Thus, although
GATA-3 target genes are beginning to be characterized in
peripheral Th2 cells, the functionally important targets of
GATA-3 remain enigmatic during the early, intermediate, and
late stage of T-cell development in the thymus, with only a
few exceptions (Fig. 2). Systematic identification of these
downstream target genes will be required to understand these
regulomes.
Upstream regulators of Gata3 expression in T cells
An equally important unanswered question is the nature of the
factor(s) that act upstream of Gata3 and control its expression
throughout T-cell development. Is Gata3 gene activation
spurred by a single predominant factor using a single enhancer
throughout T-cell life? Or, do multiple factors drive Gata3 gene
expression at each stage through individually discrete stage-
specific enhancers? Although information is not yet available
to answer this question, the currently scarce emerging data
suggests the involvement of several factors that act directly or
indirectly to regulate Gata3 at each developmental stage.
Activation of the Notch signaling pathway in hematopoietic
progenitors induces T-cell development and multiple gene
expression changes that are important for early and intermedi-
ate stages of T-cell development (29, 124). In the absence of
Notch signaling, ETPs are not generated, while LSK progeni-
tors circulating in the peripheral blood develop normally
(27). Taghon et al. (121) performed a detailed kinetic study
of fetal liver progenitors after exposure to Notch ligands in
the OP9-DL1 co-culture system. Under these conditions, DN2
and DN3 T cells first emerge at days 3 and 4, respectively.
Induction of Gata3 mRNA was first observed on day 3 in paral-
lel with elevated transcription from the Tcf7, Ptcra, and Cd3e
genes, while upregulated expression of the Notch target genes
Hes1 and Hes5 was apparent even on day 1. Since Gata3 mRNA
increases gradually between the DN1 and DN3 stages (46,
116), these data suggest that increasing Gata3 mRNA correlates
with T-cell development but not in direct response to Notch
signaling. Downregulation of the RUNX ⁄CBFb complex activ-
ity impairs the generation ⁄ expansion of ETPs, as well as their
differentiation into DN2 and DN3 cells (155). Exposure of
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fetal liver progenitors to Notch ligand for 3–5 days in
OP9-DL1 co-cultures induced Gata3 mRNA in DN1 cells, and
this induction was attenuated in Cbfbrss ⁄ ) hypomorphic mutant
hematopoietic cells (156). One interpretation of these data is
that Notch signaling may drive Gata3 gene expression through
the RUNX ⁄CBFb complex during the earliest stages of T-cell
development; a second is that development of Gata3-express-
ing cells may be impaired in Cbfbrss ⁄ ) hypomorphic mutant
cells. We note that a direct effect of the RUNX complex on
Gata3 transcription has not been demonstrated to date.
The E2a gene encodes two alternatively spliced isoforms,
E12 and E47. E47 cooperates with Notch to promote T-cell
development from bone marrow progenitors (157) and E2a-
deficient mice develop T-cell lymphomas that have a DN3-DP
phenotype (158, 159). GFI1b, which is positively regulated
by E2A, represses Gata3 in an E2a) ⁄ ) lymphoma, and inhibi-
tion of Gata3 by siRNA or by forced Gfi1b expression prevents
the expansion and survival of E2a) ⁄ ) lymphoma cells (159).
Repression of E protein activity in transgenic mice expressing
Id1 under the control of the Lck gene causes induction of Gata3
mRNA in the CD4)CD8)CD44+CD25lo cells that aberrantly
accumulate in these mice (145). These observations suggest
that E2A proteins might negatively regulate Gata3 gene
through Gfi1b. Since a role for endogenous Gfi1b, which is tran-
siently induced at the DN3 stage, has not been reported and
since the observation that forced transgenic expression of
Gfi1b under the control of the Lck promoter had little effect on
DP T-cell development (160), the physiological significance
of Gata3 repression by Gfi1b will need to be examined much
more extensively.
In DP thymocytes, GATA-3 is upregulated in response to
TCR stimulation, and its expression level correlates with the
strength of TCR signaling (56). The transcription factor MYB
is required for T-cell development from the DN3 to DN4
stage, for survival and ⁄or proliferation of DP cells, and for
development of CD4 SP cells in the thymus (161, 162). Mice
in which Myb was conditionally ablated at the DP and later
stages (Mybflox ⁄ flox:TgCd4cre) showed reduced expression of Gata3
from DP to CD4 SP cells (163). Transgenic mice that express
v-Myb, the oncogenic form of c-Myb, in T cells under the
control of the CD2 promoter ⁄ LCR displayed about two-fold
higher levels of Gata3 mRNA in DP cells after positive selection
(163). These data all implicate MYB in the regulation of Gata3
during the DP to CD4 SP cell transition.
IL4 ⁄ signal transducer and activator of transcription 6
(STAT6) and IL2 ⁄ STAT5 pathways are required for Th2 CD4+
T-cell differentiation (reviewed in 135). Forced ectopic
expression of STAT6 in Th1 cells by retroviral introduction of a
STAT6-ER fusion protein followed by tamoxifen treatment
induced Gata3 and the Th2 cytokine genes Il4 and Il5 (164).
Induction of Gata3 under Th2-favoring conditions was abro-
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Fig. 2. A hypothetical transcriptional hierarchy mediated through and by GATA-3. Factors that regulate Gata3 gene at each stage are shown. Posi-
tive regulators are shown in red arrow and negative regulators are shown in blue arrow. Factors that have been shown to directly bind Gata3 gene are
shown by a solid line, while other factors are shown with a dashed line. Factors that are regulated by GATA-3 protein positively (red arrow) or nega-
tively (blue arrow) are shown. Genes that have been show to be directly bound by GATA-3 are shown with a solid line, while genes for which evi-
dence for direct regulation is lacking or questionable are shown with dashed lines. Factors shown in gray are suggested from correlative data.
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GATA-3 (86) enhances Gata3 activation by a positive-feedback
loop. In contrast, retrovirally enforced expression of a consti-
tutively active form of STAT5a did not induce Gata3 expression
but did trigger Th2 differentiation in the absence of
IL4 ⁄ STAT6 (166). Since this Th2 induction was abrogated in
Gata3-deficient cells, endogenous GATA-3 appears to be
required for STAT5-driven Th2 differentiation (98). GATA
family proteins induce Gata3 mRNA in Stat6-deficient periph-
eral T cells (167, 168). These data indicate that autoactivation
supports Gata3 activation in Th2 cells. Mice deficient in Nfkb1
(encoding the p50 subunit of NF-jB) show impaired produc-
tion of Th2 cytokines after challenge with ovalbumin and
reduced induction of GATA-3 (169). SAP and Viperin contrib-
ute to Th2 differentiation through NF-jB (170, 171). These
data indicate that NF-jB-dependent Gata3 induction is
required for Th2 differentiation.
Inactivation of Notch signaling by germline deletion of Rbpj
or transgenic expression of a dominant negative form of its
cofactor, Mastermind-like 1, or by inactivation of Notch1 and
Notch2 compromises Th2 responses (172–176). Retroviral
transduction of the activated form of Notch in naive Stat6-defi-
cient CD4+ T cells induced Gata3 mRNA and GATA-3-depen-
dent Th2 responses (175, 176). The activated form of Notch
induces transcription of Gata3 from the Ia promoter (177) but
not from the Ib promoter, and ChIP experiments showed
binding of RBPJ to the Gata3 Ia promoter (175, 176). These
data indicate that the Notch signaling pathway induces Th2
responses at least in part by directly activating the Gata3 gene.
Although Notch signaling activates the Ia promoter, it has also
been shown that Ib transcripts are 100-fold more abundant
than Ia transcripts during Th2 activation (178). Activation of
Gata3 by the Notch signaling pathway is also observed at ear-
lier stages of T-cell development (156), and loss of either fac-
tor resulted in impaired ETP development (27, 85).
Furthermore, both Notch signaling and GATA-3 play impor-
tant roles that are independent of pre-TCR complex formation
required to pass the b-selection checkpoint (57, 179).
Although direct regulation of the Gata3 gene by Notch effec-
tors has not been shown except during peripheral stages, these
data suggest that collaborative roles for Notch and GATA-3 are
required repeatedly for T-cell development from the begin-
ning to the end of T-cell development.
CD4+CD25) T cells isolated from mice ablated for the Tcf7
gene (encoding transcription factor TCF1) or from transgenic
mice expressing ICAT, a specific inhibitor of the interaction of
TCF1 and its cofactor b-catenin, showed impaired Th2 differ-
entiation and reduced expression of Gata3 mRNA transcribed
from the Gata3 Ib promoter compared to control cells, while
transgenic mice expressing b-catenin showed the opposite
response (178). ChIP experiments revealed binding of TCF1
and b-catenin to the Gata3 Ib promoter in stimulated CD4+ T
cells (178). These data indicate that TCF1-dependent Gata3
activation is required for Th2 differentiation.
Mice ablated for Bhlhe41 (encoding transcription factor
DEC2) showed impaired Th2 differentiation, and the CD4+ T
cells isolated from those mutant mice had reduced GATA-3
mRNA in Th0 or Th2 cultures (149). Retrovirally directed
expression of DEC2 greatly induced Gata3 transcription under
Th2- or Th17-polarizing conditions, but it was only slightly
induced under Th1-polarizing conditions (149). ChIP experi-
ments using cells isolated from transgenic mice expressing
FLAG-tagged DEC2 under the control of the CD2 pro-
moter ⁄ LCR showed DEC2 binding to Gata3 (149). These data
indicate that DEC2-dependent Gata3 induction is required for
Th2 differentiation.
The transcription factor TBET, a master regulator of Th1 cell
differentiation, represses the Gata3 gene (180). In addition to
exerting transcriptional control by Gata3 repression, TBET may
bind directly to GATA-3 protein and thereby sequester it from
binding to target DNA sites (181). RUNX1, which promotes
Th1 differentiation, represses the Gata3 gene (182). Addition-
ally, RUNX3, which cooperates with TBET to promote Th1
differentiation, interacts with GATA-3 and suppresses its tran-
scriptional activity (183). In contrast to its repressive effect at
the Th1 stage, the RUNX ⁄CBFb complex may actually func-
tion as an activator of Gata3 at early stages (156). Since both
GATA-3 and RUNX complexes play important roles at multi-
ple stages (early, late, and peripheral) of T lymphopoiesis, it
will be intriguing to elucidate the similarities and differences
of their possible interplay at each stage. TGFb supports Th17
differentiation by repressing Gata3 and Stat4 (184). The aryl
hydrocarbon receptor (AhR) and its agonist M50354 also
seem to skew the Th1 ⁄Th2 balance toward Th1 dominance by
repressing Gata3 (185).
These upstream factors have all been implicated to exert
direct control over Gata3 transcription through the promoter
or putative enhancers of the Gata3 gene (Table 3), or indirectly
by controlling other direct regulators or by modifying chro-
matin status within the locus (Fig. 2). We have found that
Gata3 is expressed in up to two dozen discrete tissue types,
and each expression pattern appears to be driven by a discrete,
individual tissue-specific enhancer element (103, 106, 186–
188, our unpublished data). To initially localize many of these
regulatory elements, mice harboring reporter transgenes
containing as little as 300 bp to mice bearing as much as
662 kbp of Gata3 genomic DNA have been examined in trans-
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fection and transgenic reporter assays. These studies identified
regulatory elements for Gata3 that specify its expression in the
1st and 2nd branchial arches, the genital tubercle ⁄ cloaca, in
mammary epithelial cells, hair follicles, vestibulocochlear gan-
glia, the central nervous system (three separate enhancers),
the eye, the ectoplacental cone ⁄ placenta, the thyroid gland,
the mesonephric and metanephric tubules of the embryonic
kidney, the semicircular canals of the inner ear and primordia
specifying the endocardial cushions. Perhaps surprisingly,
these studies also indicated that the regulatory elements that
control Gata3 expression in the sympathetic nervous system
probably lie beyond 451 kbp 5¢ or 211 kbp 3¢ (as defined by
one transgenic YAC; the genome sequence-revised endpoints)
with respect to the GATA-3 translational start site. However,
since all these studies were performed between days 10.5 and
14.5 of embryogenesis, the element specifying Gata3 expres-
sion in mature T cells was not examined (since the first DP
cells develop at around e16.5) (189). We have recently found
that this same 662 kbp Gata3 YAC does not harbor sufficient
sequence information to direct reporter gene expression in
adult thymocytes, but intriguingly we have now identified
multiple overlapping bacterial artificial chromosomes (BACs)
that can activate a Gata3-directed reporter gene in T cells in vivo
(our unpublished observations). The developmental and tem-
poral specificity of this regulatory sequence(s) may reveal pro-
found new insights into the regulation of Gata3, and therefore
indirectly into the molecular mechanisms controlling T-cell
development.
Conclusions
We have reviewed here the requirements for and known func-
tions of GATA-3 in T-lineage cells from the earliest T-cell pro-
genitors in the thymus all the way to peripheral CD4+ Th2
cells. Growing evidence has begun to reveal the hierarchical
positioning of GATA-3 and other molecules in these impor-
tant developmental processes, especially in peripheral Th2 cell
activation. In contrast, only a handful of factors have been
demonstrated to interact with GATA-3 during T-cell develop-
ment in the thymus. The development of next-generation
sequencing technology has made it possible to comprehen-
sively identify direct targets of a transcription factor through
whole genome ChIP sequencing and whole genome mRNA
sequencing. Subsequent molecular biological confirmation of
the functional importance of these genomic indications will
be essential to understand the transcriptional hierarchy medi-
ated by and through GATA-3. To these ends, the Gata3 hypo-
morphic mutant as well as the Gata3 null and conditional
alleles should prove to be indispensable tools. As described
above, a skeletal network description for immature T-cell
development has been published and should serve as an out-
standing framework for probing aspects of transcriptional reg-
ulation during immature T-cell development (145). Although
much more data will be required to elaborate the influences
and nuances in this network that will produce a precisely
refined picture of the process as a whole, overwhelming evi-
dence supports the hypothesis that GATA-3 must play a central
role at multiple stages of T-cell development, and therefore, it
must be a fundamental contributor to many steps in the over-
all framework from the birth to the death of T cells. It will be
fascinating both to test mechanistically how the network is
maintained as well as to learn what (known and currently
unknown) molecules participate in the establishment of T-cell
development.
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